4//SEC Filing
Aguilar Laura K. 4
Accession 0000899243-22-017477
CIK 0001841387other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 6:07 PM ET
Size
14.6 KB
Accession
0000899243-22-017477
Insider Transaction Report
Form 4
Aguilar Laura K.
10% Owner
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-05-06−76,717→ 0 totalExercise: $1.46Exp: 2028-11-13→ Common Stock (76,717 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-06−76,717→ 0 totalExercise: $1.46Exp: 2028-11-13→ Common Stock (76,717 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-06−17,901→ 0 totalExercise: $1.46Exp: 2028-08-17→ Common Stock (17,901 underlying) - Exercise/Conversion
Common Stock
2022-05-06$1.46/sh+171,335$250,149→ 1,102,374 total - Tax Payment
Common Stock
2022-05-06$3.65/sh−68,534$250,149→ 1,033,840 total
Holdings
- 2,013,100(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Includes 32,399 shares of common stock held jointly with spouse.
- [F2]Represents a net exercise of outstanding stock options. These shares were resold to the Issuer as payment of the exercise price, based on the closing price of the Issuer's common stock on May 5, 2022 of $3.65 per share.
- [F3]Shares held by the Laura K. Aguilar 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.
- [F4]This option is fully vested and exercisable as of the date hereof.
- [F5]Includes options that were previously subject to performance vesting criteria. Upon the Reporting Person's termination as an officer of the Issuer, the vesting conditions were waived, and the shares underlying this option became fully vested and exercisable.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873915
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 6:07 PM ET
- Size
- 14.6 KB